Background: To describe cases of retinal vascular events shortly after administration of
mRNA or adenoviral-vectored COVID-19 vaccines. Design: Retrospective, multicenter case …

Introduction Published data on possible ocular adverse events potentially associated with
vaccination with the SARS-Cov-2 mRNA-1237 vaccine are scarce. In this report, we …

Introduction Increased risk of thromboembolic events has been associated with SARS-CoV-
2 infections and more recently, with COVID-19 vaccination. To date, however, there are no …

Abstract Coronavirus disease 2019 (COVID-19) vaccines are associated with several ocular
manifestations. Emerging evidence has been reported; however, the causality between the …

Purpose Potential retinal adverse events after COVID-19 vaccinations reported previously
include paracentral acute middle maculopathy (PAMM), acute macular neuroretinopathy …

Purpose: The primary purpose of this study was to assess vascular retinal findings
temporally related to COVID-19 vaccination. With greater information regarding all possible …

Purpose To report a case of a branch retinal vein occlusion (BRVO) following mRNA COVID-
19 vaccination. Observations A 34-year-old healthy male presented with blurriness in the …

Importance New-onset retinal vascular occlusion (RVO) occurring acutely after messenger
RNA (mRNA) COVID-19 vaccination has been described in recent literature. Because RVO …

To report retinal vein occlusion (RVO) and age-related macular degeneration (AMD)-related
submacular hemorrhage developing after administration of SARS-CoV-2 vaccines, a single …

Purpose Abnormal hypercoagulability and increased thromboembolic risk are common in
patients with coronavirus disease (COVID-19). COVID-19 has been suggested to cause …